Sign in

CIK 0001551306

  • Large accelerated filer

Progyny, Inc.

Sign in to watch
Ticker
PGNY
Exchange
Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272220139
Phone
+1 212-888-3124
Business address
1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
Former names
Auxogyn, Inc., Auxogyn Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,674,844
in 10 filings, $22.0M under 10b5-1 plans

Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-02 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −13,998 1,536,024
2023-12-27 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +76,031 $3.95 $301K 164,470
2023-12-27 Schlanger David J Executive Chairman Sale 10b5-1 −76,031 $37.66 $2.9M 88,439
2023-12-27 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −76,031 1,550,022
2023-12-26 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +80,000 $3.95 $316K 168,439
2023-12-26 Schlanger David J Executive Chairman Sale 10b5-1 −80,000 $37.93 $3.0M 88,439
2023-12-26 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −80,000 1,626,053
2023-12-22 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +80,000 $3.95 $316K 168,439
2023-12-22 Schlanger David J Executive Chairman Sale 10b5-1 −80,000 $38.11 $3.0M 88,439
2023-12-22 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −80,000 1,706,053
2023-12-21 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +80,000 $3.95 $316K 168,439
2023-12-21 Schlanger David J Executive Chairman Sale 10b5-1 −80,000 $37.65 $3.0M 88,439
2023-12-21 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −80,000 1,786,053
2023-12-20 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +2,906 $3.95 $11K 91,345
2023-12-20 Schlanger David J Executive Chairman Sale 10b5-1 −2,906 $37.50 $109K 88,439
2023-12-20 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −2,906 1,866,053
2023-12-14 Schlanger David J Executive Chairman Exercise or conversion 10b5-1 +1,063 $3.95 $4K 89,502
2023-12-14 Schlanger David J Executive Chairman Sale 10b5-1 −1,063 $37.53 $40K 88,439
2023-12-14 Schlanger David J Executive Chairman Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −1,063 1,868,959
2023-12-11 Livingston Mark S. CHIEF FINANCIAL OFFICER Shares withheld for taxes −112 $36.26 $4K 49,871

Page 17 of 77 · 1,524 trades